SSE

Banco Itaú Chile Announces Third Quarter 2023 Management Discussion & Analysis Report

Retrieved on: 
Tuesday, October 31, 2023
SSE, IR, Webcast, ID, Conference, NYSE, ITCL, Telephone, Internet service provider, Broadcasting

SANTIAGO, Chile, Oct. 31, 2023 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (NYSE: ITCL; SSE: ITAUCL) announced today its Management Discussion & Analysis Report (“MD&A Report”) for the third quarter ended September 30, 2023.

Key Points: 
  • SANTIAGO, Chile, Oct. 31, 2023 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (NYSE: ITCL; SSE: ITAUCL) announced today its Management Discussion & Analysis Report (“MD&A Report”) for the third quarter ended September 30, 2023.
  • For the full MD&A Report, please refer to the following link:
    On Monday, November 6, 2023, at 11:00 A.M. Santiago time (9:00 A.M.
  • ET), the Company’s management team will host a conference call to discuss the financial results.
  • The webcast can be found at:
    Webcast will be available on-demand via the same address as the live event afterwards.

Banco Santander-Chile Announces Third Quarter 2023 Earnings

Retrieved on: 
Tuesday, October 31, 2023
Banco Santander Chile, LCR, SME, Insurance, SSE, MPR, Yoy, Moody's Investors Service, Bank, Index, NYSE, NPL, ESG, BIS, Basel, S&P Global Ratings, Government, ADR, Getnet Wale, KBRA, Investment banking, NPS, Corporation, Quarter, NII, Japan Credit Rating Agency, Acceleration, Life, Retail banking, Central Bank of Myanmar, Growth, Central bank, RWA, MIN, Travel, CLP, Depreciation, BSAC, Credit, CIB, Investment, YTD, UF, JPY, COVID-19, Rare-earth element, Cryptocurrency

SANTIAGO, Chile, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its resultsi for the nine-month period ended September 30, 2023, and third quarter 2023 (3Q23).

Key Points: 
  • SANTIAGO, Chile, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its resultsi for the nine-month period ended September 30, 2023, and third quarter 2023 (3Q23).
  • During the third quarter of 2023, the Central Bank began to cut the MPR from 11.25% to 10.25% at the end of July to 9.50% in September.
  • Our earnings webcast will be held on Friday, November 3, 2023 at 10am New York time.
  • The BIS capital ratio as of September 30, 2023, was 17.1%, with a core capital ratio of 10.7%.

Itaú Chile Files Material Event Notice announcing the termination of the program of its American Depositary Shares (“ADSs”) registered in the United States of America

Retrieved on: 
Monday, October 30, 2023
SSE, Security (finance), NYSE, Deposit, Bangladesh Securities and Exchange Commission, Financial market, American depositary receipt, ITCL, Cryptocurrency

SANTIAGO, Chile, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (NYSE: ITCL; SSE: ITAUCL) announced that it filed today a Material Event Notice with the Chilean Commission for the Financial Market (Comisión para el Mercado Financiero) reporting the initiation of the process to (i) terminate the program of its American Depositary Shares (“ADSs”) registered in the United States of America, (ii) cancel the registration of its ADSs with the Securities and Exchange Commission, (iii) delist its ADSs from the New York Stock Exchange, and (iv) terminate the Deposit Agreement under which the ADSs are issued.

Key Points: 
  • SANTIAGO, Chile, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (NYSE: ITCL; SSE: ITAUCL) announced that it filed today a Material Event Notice with the Chilean Commission for the Financial Market (Comisión para el Mercado Financiero) reporting the initiation of the process to (i) terminate the program of its American Depositary Shares (“ADSs”) registered in the United States of America, (ii) cancel the registration of its ADSs with the Securities and Exchange Commission, (iii) delist its ADSs from the New York Stock Exchange, and (iv) terminate the Deposit Agreement under which the ADSs are issued.
  • The full Material Event Notice is available on the company’s investor relations website at ir.itau.cl .

Check Point Software Reports 2023 Third Quarter Financial Results

Retrieved on: 
Monday, October 30, 2023
SSE, Security Service, SASE, Check Point, Conference, Perimeter 81, GAAP, Acquisition, Cash balance plan, Tax, Security, Webcast, SAN, Software as a service, Video game, Cryptocurrency, Bank

SAN CARLOS, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd. (NASDAQ: CHKP), today announced its financial results for the third quarter ended September 30, 2023.

Key Points: 
  • SAN CARLOS, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd. (NASDAQ: CHKP), today announced its financial results for the third quarter ended September 30, 2023.
  • We achieved total revenues near the top of our forecast range, with earnings per share hitting the peak,” stated Gil Shwed, Founder and CEO of Check Point Software.
  • Financial Highlights for the Third Quarter of 2023:
    Total Revenues: $596 million compared to $578 million in the third quarter of 2022, a 3 percent increase year over year.
  • GAAP Operating Income: $226 million compared to $221 million in the third quarter of 2022, representing 38 percent of revenues in the third quarter of 2023 and 2022, respectively.

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Retrieved on: 
Friday, October 27, 2023
HKEX, FDA, Junshi, SSE, PD-L1, Glomus tumor, Skull, Survival, Harvard Medical School, Primary tumor, Incidence, Aes, Food, Progression-free survival, DCR, Sun, Cisplatin, PFS, Conference, PD-1, CHRS, CCR8, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Research, HIV disease progression rates, NPC, Assistant professor, Immune system, Neoplasm, Risk, Pharynx, Radiation, ORR, Platinum, Tumor microenvironment, Cancer, Ira Pastan, Patient, OS, Death, Toxicity, Nose, Palladium, Pharmaceutical industry

REDWOOD CITY, Calif. and SHANGHAI, China, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, NASDAQ: CHRS), and  Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences, HKEX: 1877; SSE: 688180) today announced that the U.S. Food and Drug Administration (FDA) approved LOQTORZI™ (toripalimab-tpzi) in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced NPC, and as monotherapy for the treatment of adults with recurrent, unresectable, or metastatic NPC with disease progression on or after platinum-containing chemotherapy. The approval was based on results of the JUPITER-02 Phase 3 study and the POLARIS-02 Phase 2 study and is irrespective of a patient’s PD-L1 status. LOQTORZI is a next-generation, programmed death receptor-1 (PD-1) monoclonal antibody that blocks PD-1 ligands PD-L1 and PD-L2 with high potency at a unique site on the PD-1 receptor, enabling the immune system to activate and kill the tumor.

Key Points: 
  • The approval was based on results of the JUPITER-02 Phase 3 study and the POLARIS-02 Phase 2 study and is irrespective of a patient’s PD-L1 status.
  • LOQTORZI also demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), with treatment resulting in a 37% reduction in the risk of death versus chemotherapy alone.
  • “Following etesevimab, toripalimab has become Junshi Biosciences’ second product to receive FDA approval for commercialization—an achievement that will further enhance the company’s international presence.
  • Currently, the establishment of toripalimab’s global commercialization network is in progress, and the network aims to span over 50 countries.

Junshi Biosciences Presents 11 Clinical Trials of Toripalimab at the ESMO Congress 2023

Retrieved on: 
Friday, October 27, 2023
Junshi, Shanghai Jiao Tong University School of Medicine, SSE, Kidney cancer, Cervical cancer, Trial of the century, Manuscript, Axitinib, ESMO, III, Renal cell carcinoma, Lung cancer, Colorectal cancer, Head, Congress, PFS, Renji Hospital, Carcinoma, Impact, Thymus, Research, HIV disease progression rates, RCC, Development, Apoptosis, Clinical trial, Risk, Breast cancer, Immunotherapy, ORR, European Society for Medical Oncology, Patient, Hospital, Death, IRC, Lymphoma, Pharmaceutical industry

At the ESMO Congress 2023, Junshi Bioscience showcased a total of 11 clinical trials involving the groundbreaking immune-oncology drug, toripalimab (anti-PD-1 monoclonal antibody), in the forms of 1 late-breaking abstract, 2 proffered paper oral presentations, and 8 posters.

Key Points: 
  • At the ESMO Congress 2023, Junshi Bioscience showcased a total of 11 clinical trials involving the groundbreaking immune-oncology drug, toripalimab (anti-PD-1 monoclonal antibody), in the forms of 1 late-breaking abstract, 2 proffered paper oral presentations, and 8 posters.
  • “This year’s ESMO Congress highlighted the most recent results from 11 clinical studies conducted with our core product, toripalimab,” said Dr. Jianjun ZOU, Global Research and Development President of Junshi Biosciences.
  • Study findings were unveiled for the first time during a proffered paper session at the ESMO Congress.
  • In terms of safety, toripalimab combined with chemotherapy has a manageable safety profile and no new safety signals were identified.

Windstream Enterprise Unveils Global Availability of its Comprehensive SASE and SSE Cybersecurity Solutions with Cato Networks

Retrieved on: 
Thursday, November 2, 2023
Data Management, Security, Technology, Telecommunications, Software, Networks, Internet, Cloud, SSE, Security Service, SASE, Cato Networks, Pops, Organization, Secure access service edge, Cato, European, Connect, Partnership, Gartner, GDPR, Online shopping, Cryptocurrency

Windstream Enterprise (WE), a leading IT managed services provider, today announced that its Secure Access Service Edge (SASE) and Security Service Edge (SSE) solutions, powered by Cato Networks, are available for U.S.-based companies that operate internationally.

Key Points: 
  • Windstream Enterprise (WE), a leading IT managed services provider, today announced that its Secure Access Service Edge (SASE) and Security Service Edge (SSE) solutions, powered by Cato Networks, are available for U.S.-based companies that operate internationally.
  • This gives customers the assurance that all of their locations are secure in whichever country they operate.
  • Windstream Enterprise’s cloud-native and fully managed SASE and SSE services, powered by Cato SASE Cloud, leverage Cato Networks’ dedicated, private backbone with more than 80 points of presence (PoPs) worldwide to provide users everywhere with optimized secure access to corporate resources and websites.
  • Windstream Enterprise is the first North American-based managed service provider to offer this international solution.

ExtraHop® Launches Zero Trust Extension for Netskope

Retrieved on: 
Tuesday, October 31, 2023
Technology, Networks, Data Management, Security, Cloud, Research, XDR, SSE, SIEM, SOAR, SVP, Architecture, IDC, Organization, Cognition and Neuroergonomics (CaN) Collaborative Technology Alliance, Trust, SASE, HP Enterprise Security Products, Gartner, NDR, Software as a service, Mobile phone, Online shopping, Risk management, ExtraHop Networks

ExtraHop , a leader in cloud-native network detection and response (NDR), today announced the launch of the ExtraHop Zero Trust Extension for Netskope.

Key Points: 
  • ExtraHop , a leader in cloud-native network detection and response (NDR), today announced the launch of the ExtraHop Zero Trust Extension for Netskope.
  • As part of an early access program, enterprises using the ExtraHop Zero Trust Extension for Netskope can:
    Close gaps in zero trust architectures and reduce risks by gaining visibility into previously inaccessible network segments.
  • “The ExtraHop Zero Trust Extension for Netskope will move enterprises a step ahead in their zero trust journey.
  • With a well-integrated solution from ExtraHop and Netskope, enterprises can confidently move forward with their zero trust implementations.”

Equipped with Shanghai Electric's Offshore Tribune, World's First Deep-Sea Floating Wind Energy Project Integrated with Marine Ranching Completes

Retrieved on: 
Friday, November 3, 2023
SSE, Water, National Marine Sanctuary of American Samoa, SEHK, Carbon, Wind, Electricity, Partnership, Safety, DVN, Shanghai Electric, Aquaculture, Renewable energy

SHANGHAI, Nov. 3, 2023 /PRNewswire/ -- The world's first maritime renewable energy project that combines deep-sea floating wind energy and aquaculture has been completed in China.

Key Points: 
  • SHANGHAI, Nov. 3, 2023 /PRNewswire/ -- The world's first maritime renewable energy project that combines deep-sea floating wind energy and aquaculture has been completed in China.
  • Marking a significant step forward for China's wind energy sector, the project is developed by Longyuan Power Group, with Shanghai Electric Wind Power Group (the Wind Power Group), a subsidiary of Shanghai Electric (SEHK: 2727, SSE: 601727), providing the power generation equipment and towers of the offshore turbines.
  • On the safety front, Shanghai Electric Wind Power Group uses a multi-pronged approach to ensure the reliability of the project throughout its entire lifecycle.
  • The Company also developed a custom-built intelligent terminal system for floating wind turbines, enhancing reliability to ensure the safe and consistent operation of the turbines while maximizing wind utilization.

Equipped with Shanghai Electric's Offshore Tribune, World's First Deep-Sea Floating Wind Energy Project Integrated with Marine Ranching Completes

Retrieved on: 
Friday, November 3, 2023
SSE, Water, National Marine Sanctuary of American Samoa, SEHK, Carbon, Wind, Electricity, Multimedia, Partnership, Safety, DVN, Shanghai Electric, Aquaculture, Renewable energy

SHANGHAI, Nov. 2, 2023 /PRNewswire/ -- The world's first maritime renewable energy project that combines deep-sea floating wind energy and aquaculture has been completed in China.

Key Points: 
  • SHANGHAI, Nov. 2, 2023 /PRNewswire/ -- The world's first maritime renewable energy project that combines deep-sea floating wind energy and aquaculture has been completed in China.
  • Marking a significant step forward for China's wind energy sector, the project is developed by Longyuan Power Group, with Shanghai Electric Wind Power Group (the Wind Power Group), a subsidiary of Shanghai Electric (SEHK: 2727, SSE: 601727), providing the power generation equipment and towers of the offshore turbines.
  • With the deployment of offshore wind power extending beyond coastal regions into deep-sea locations, Shanghai Electric Wind Power Group is fully prepared to lead the way in the development, installation, and operation of floating wind power and deep-sea wind power projects, equipping itself with state-of-the-art technology and leveraging its extensive expertise to create solutions for multi-purpose new energy infrastructure.
  • On the safety front, Shanghai Electric Wind Power Group uses a multi-pronged approach to ensure the reliability of the project throughout its entire lifecycle.